DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years ...
In this week’s Pharma Pulse, GoodRx expands an employer offering built on manufacturer pricing for GLP-1 obesity drugs, a ...
Why outdated paper prescribing information is creating unnecessary cost, complexity and friction across a modern ...
EVERSANA is folding Estima Scientific's AI-powered HEOR tools into its market access offerings as its CEO says evidence ...
Walgreens adds GLP-1 coverage navigation, Medicare Bridge support and pharmacist outreach to its virtual weight management ...
BMS’s Kevin Cook explains why digital capability is becoming a must-have for strategic CMO partners and why the next phase ...
Agentic AI is moving biopharma from tools that inform decisions to systems that execute them, reshaping discovery, clinical ...
At LogiPharma USA 2026, Freehand's Nitin Jayakrishnan explains why AI and the people supply chain will shape pharma supply strategy. AI is no longer a future consideration for pharmaceutical supply ...
Swisslog’s Garrett Freeman says 2027 is the year pharma’s onshoring commitments turn into operational capacity, with physical AI and direct-to-patient growth also on his radar.
At LogiPharma USA 2026, Cold Chain Technologies' Vijay Paliwal discusses reusable shippers, PCM innovation and AI's role in cold chain risk. The cold chain packaging sector is innovating faster than ...
Cencora’s Matt Sample and Gregg Gorniak explain why AI should recommend, not decide, and why pharma needs an agent strategy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results